← Eichor
Study identifier: NCT06123481 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Autologous Bone Marrow Aspirate Treatment for Early-Stage Osteonecrosis

Condition: Osteonecrosis of the Femoral Head · Avascular Necrosis of the Femoral Head  ·  Sponsor: Johns Hopkins University

PhaseNA
Planned participants192
Who can joinAll sexes, 18 Years to 90 Years
Healthy volunteersNo

About this study

Osteonecrosis of the femoral head (ONFH) is a debilitating musculoskeletal disease that is characterized by localized death of bone cells and associated cellular elements within the subchondral bone. If it progresses, it results in the collapse of the femoral head (ball part of the hip) giving rise to secondary arthritis. This condition is associated with marked pain and loss of function, often necessitating a joint replacement. Due to the relatively young age of onset of ONFH (often in 20s and 30s), there is great interest in utilizing joint-preserving procedures prior to the need for joint replacement. Joint-preserving procedures include core decompression (CD) with and without bone grafts or cells, vascularized and non-vascularized bone grafting, as well as osteotomies. Inconsistent results for each of these procedures have been reported and there are no Clinical Practice Guidelines or medical community consensus opinions regarding the treatment of early-stage ONFH. The hypothesis to be tested is "Participants who have early-stage ONFH undergoing CD augmented with autogenous bone marrow aspirate concentrate will have better clinical and radiological outcomes than CD alone." This multi-center randomized controlled trial for early-stage ONFH is prospective and controlled for participant stage (only early-stage pre-collapse individuals) and surgical technique. Participants will be evaluated as per routine surgical follow-up, and at 6 months (telemedicine), 1- and 2- years usi…

This description comes directly from the study's public registry record.

Talk to the study team

Lynne C Jones, PhD  ·  (410) 550-4001  ·  ljones3@jhmi.edu

Stuart Goodman, MD, PhD  ·  650-721-7662  ·  goodbone@stanford.edu

Always discuss trial participation with your own doctor first.

Locations (10)

University of Southern CaliforniaLos Angeles, California, United StatesRecruiting
Stanford UniversityStanford, California, United StatesRecruiting
Sinai Hospital of BaltimoreBaltimore, Maryland, United StatesRecruiting
Johns Hopkins UniversityBaltimore, Maryland, United StatesRecruiting
University of MinnesotaMinneapolis, Minnesota, United StatesRecruiting
Mayo ClinicRochester, Minnesota, United StatesRecruiting
NYU Langone Health Orthopedic HospitalNew York, New York, United StatesRecruiting
Cleveland ClinicCleveland, Ohio, United StatesRecruiting
University of PennsylvaniaPhiladelphia, Pennsylvania, United StatesRecruiting
University of VirginiaCharlottesville, Virginia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06123481